Search Results - "Soleda M"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    1935P Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment.

    Authors: Priano, I. Caro, R. Carbonell, C. et al.

    Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1103-S1103. 1p.

    Save to List
  2. 2

    1637P Impact of immune-related adverse events (irAEs) and survival (OS) in a cohort of MPM patients (p) treated with immunotherapy (IT).

    Authors: Cedres Perez, S.M. Valdivia, A. Assaf, J.D. et al.

    Source: Annals of Oncology. 2022 Supplement 7, Vol. 33, pS1290-S1290. 1p.

    Save to List
  3. 3

    Somatic copy number alterations profiling in non-small cell lung cancer and their correlation with clinical efficacy in first-line treatment.

    Authors: Priano I Amat R Carbonell C et al.

    Source: Genome medicine [Genome Med] 2026 Apr 01; Vol. 18 (1). Date of Electronic Publication: 2026 Apr 01.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE

    Save to List
  4. 4

    Dynamic changes in circulating tumor DNA assessed by shallow whole-genome sequencing associate with clinical efficacy of checkpoint inhibitors in NSCLC.

    Authors: Carbonell C Frigola J Pardo N et al.

    Source: Molecular oncology [Mol Oncol] 2023 May; Vol. 17 (5), pp. 779-791. Date of Electronic Publication: 2023 Mar 21.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  5. 5

    The impact of decision tools during oncological consultation with lung cancer patients: A systematic review within the I3LUNG project.

    Authors: Sebri V Marzorati C Dorangricchia P et al.

    Source: Cancer medicine [Cancer Med] 2024 May; Vol. 13 (9), pp. e7159.

    Publication Type: Journal Article; Systematic Review

    Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE

    HTML Full Text PDF Full Text
    Save to List
  6. 6

    High levels of chromosomal aberrations negatively associate with benefit to checkpoint inhibition in NSCLC.

    Authors: Frigola J Carbonell C Irazno P et al.

    Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Apr; Vol. 10 (4).

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

    Save to List

Search Tools: